Showing results (1-10 of 419) with videos related to

Sort By:
Pageof 42
BMC Bioinformatics|October 15, 2024
repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate methodDeyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, et al.
BMC Research Notes|July 3, 2025
Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samplesDeyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, et al.
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
Blood|December 5, 2018
FBXW7 mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLLViola Close, William Close, Sabrina Julia Kugler, et al.
Haematologica|March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapyMarc Zapatka, Eugen Tausch, Selcen Öztürk, et al.
Blood|March 31, 2012
CLL and deletion 13q14: merely the miRs?Daniel Mertens, Stephan Stilgenbauer
Leukemia|July 14, 2019
Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLLDeyan Yordanov Yosifov, Irina Idler, Nupur Bhattacharya, et al.
Clinics in Laboratory Medicine|November 29, 2011
Genetics of chronic lymphocytic leukemiaAndrea Schnaiter, Daniel Mertens, Stephan Stilgenbauer
International Journal of Cancer|May 16, 2014
Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6Nupur Bhattacharya, Michaela Reichenzeller, Maiwen Caudron-Herger, et al.
Oncology Research and Treatment|February 19, 2016
Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic LeukemiaEugen Tausch, Daniel Mertens, Stephan Stilgenbauer
Pageof 42